Federal Circuit Rules For Pfizer In Teva's Challenge To Zoloft Patent
In a closely watched test of key provisions of the Hatch-Waxman Act, the U.S. Court of Appeals for the Federal Circuit has ruled for Pfizer in a lawsuit brought by Israeli...To view the full article, register now.
Already a subscriber? Click here to view full article